Skip to main content

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NAVIGATE

Tell us what you think about gonorrhoea vaccines

About the NAVIGATE Study

There is the possibility that, in future, teenagers, young adults, or people at higher risk of sexually transmitted infections (STI) may be offered a vaccine to protect them against an STI called gonorrhoea.  Currently, the UK government is considering offering this vaccine to men who have sex with other men, and others who are at higher risk of getting an STI, for example, people who have had an STI before.  
 
The vaccine they are considering is the vaccine that is already given to babies to protect against Meningitis B. Research has shown that some meningitis B vaccines can offer some protection against gonorrhoea too. If giving the vaccine to people at most risk of gonorrhoea works well and the data shows the vaccine is effective, there is the potential to consider vaccination of other groups. For example, vaccination could be recommended for young teenagers in the future, to protect them before they become sexually active.   

navigate_logo.png

NAVIGATE: Navigating Attitudes to Vaccination Implementation for Gonorrhoea in the UK: Acceptability, Trust and Engagement

To shape this programme effectively, we need to understand public opinion on vaccinating teenagers against gonorrhoea. We're looking for input from:
 

  • School students (13 or 14 year olds) and their parents,
  • Young adults aged 18-24 years old,
  • Sexual health service users.

Your feedback is crucial to determine:
 

  • Acceptance of the vaccine,
  • Necessary information to make informed decisions,
  • Logistic considerations to ensure easy access to the vaccine.

Take Part online NOW

The survey should take roughly 10-15 minutes to complete.

To take part, choose the appropriate information sheet and survey link below.